Paper17154643
A review of calcium channel antagonists in the treatment of pediatric hypertension.
Sahney S. Paediatr Drugs, 2006. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. A review of calcium channel antagonists in the treatment of pediatric hypertension. Papers, record 17154643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17154643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Channel Blockers | Major topic |
| Hypertension | Major topic |
| Amiodarone | |
| Child | |
| Felodipine | |
| Humans | |
| Isradipine | |
| Nicardipine | |
| Nifedipine | |
| Verapamil |
Source PubMed
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9249636 | Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. | J Periodontol | 1997 | https://conductscience.org/library/papers/9249636 | PubMed |
| 2 | 11304651 | Nicardipine to control mean arterial pressure after cardiothoracic surgery in infants and children. | Am J Ther | 2001 | https://conductscience.org/library/papers/11304651 | PubMed |
| 3 | 7637142 | The risk of myocardial infarction associated with antihypertensive drug therapies. | JAMA | 1995 | https://conductscience.org/library/papers/7637142 | PubMed |
| 4 | 8521773 | Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease. | Drugs | 1995 | https://conductscience.org/library/papers/8521773 | PubMed |
| 5 | 9561341 | The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal. | Drugs | 1998 | https://conductscience.org/library/papers/9561341 | PubMed |
| 6 | 6637932 | Nifedipine in hypertensive emergencies of children. | Am J Dis Child | 1983 | https://conductscience.org/library/papers/6637932 | PubMed |
| 7 | 3221006 | Treatment of hypertensive crisis in children with nifedipine. | Intensive Care Med | 1988 | https://conductscience.org/library/papers/3221006 | PubMed |
| 8 | 1989801 | Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. IV Nicardipine Study Group. | Chest | 1991 | https://conductscience.org/library/papers/1989801 | PubMed |
| 9 | 3797155 | Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. | Pediatrics | 1987 | https://conductscience.org/library/papers/3797155 | PubMed |
| 10 | 8643207 | Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis. | Nephrol Dial Transplant | 1995 | https://conductscience.org/library/papers/8643207 | PubMed |
| 11 | 8885941 | Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. | Pediatrics | 1996 | https://conductscience.org/library/papers/8885941 | PubMed |
| 12 | 2666449 | New therapeutic modalities in hypertension: focus on a new calcium antagonist-nicardipine. | J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2666449 | PubMed |
| 13 | 12003700 | The use of calcium antagonists in the treatment of hypertensive persons with kidney disease. | Curr Hypertens Rep | 2002 | https://conductscience.org/library/papers/12003700 | PubMed |
| 14 | 3544786 | Short- and long-term effects of calcium entry blockers on the kidney. | Am J Cardiol | 1987 | https://conductscience.org/library/papers/3544786 | PubMed |
| 15 | 10562973 | Use of calcium-channel blockers in pediatric renal transplant recipients. | Pediatr Transplant | 1999 | https://conductscience.org/library/papers/10562973 | PubMed |
| 16 | 9607186 | Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers? | Kidney Int | 1998 | https://conductscience.org/library/papers/9607186 | PubMed |
| 17 | 9273824 | Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. | Ann Intern Med | 1997 | https://conductscience.org/library/papers/9273824 | PubMed |
| 18 | 2467131 | Pharmacokinetics of amlodipine in renal impairment. | J Cardiovasc Pharmacol | 1988 | https://conductscience.org/library/papers/2467131 | PubMed |
| 19 | 1711448 | Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. | Drugs | 1991 | https://conductscience.org/library/papers/1711448 | PubMed |
| 20 | 10231447 | Class differences in the effects of calcium channel blockers in the rat remnant kidney model. | Kidney Int | 1999 | https://conductscience.org/library/papers/10231447 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42080794 | Suppression of Calcium Influx Reduces Coxsackievirus B3 Lethality With Elevated Interferon Beta Responses in Mice. | J Med Virol | 2026 | https://conductscience.org/library/papers/42080794 | PubMed |
| 40061283 | Combinatorial approach to treat iron overload cardiomyopathy in pediatric patients with thalassemia-major: A systematic review and meta-analysis. | World J Cardiol | 2025 | https://conductscience.org/library/papers/40061283 | PubMed |
| 38371660 | Pediatric antiarrhythmics and toxicity: A clinical review. | J Am Coll Emerg Physicians Open | 2024 | https://conductscience.org/library/papers/38371660 | PubMed |
| 37731443 | Calcium Channel Blocker Overdose Causes Acute Respiratory Distress Syndrome and Acute Kidney Injury in a 15-Year-Old Female. | Cureus | 2023 | https://conductscience.org/library/papers/37731443 | PubMed |
| 36839878 | Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839878 | PubMed |
| 36677842 | Synthesis of Dihydropyrimidines: Isosteres of Nifedipine and Evaluation of Their Calcium Channel Blocking Efficiency. | Molecules | 2023 | https://conductscience.org/library/papers/36677842 | PubMed |
| 33194923 | Hypertensive Crisis in Pediatric Patients: An Overview. | Front Pediatr | 2020 | https://conductscience.org/library/papers/33194923 | PubMed |
| 31676933 | Antihypertensive agents: a long way to safe drug prescribing in children. | Pediatr Nephrol | 2020 | https://conductscience.org/library/papers/31676933 | PubMed |
| 28256607 | The Rotavirus NSP4 Viroporin Domain is a Calcium-conducting Ion Channel. | Sci Rep | 2017 | https://conductscience.org/library/papers/28256607 | PubMed |
| 27621495 | Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions. | Can J Hosp Pharm | 2016 | https://conductscience.org/library/papers/27621495 | PubMed |
| 24908135 | Pediatric hypertensive emergencies. | Curr Hypertens Rep | 2014 | https://conductscience.org/library/papers/24908135 | PubMed |
| 20233185 | Superior palatability of crushed lercanidipine compared with amlodipine among children. | Br J Clin Pharmacol | 2010 | https://conductscience.org/library/papers/20233185 | PubMed |
| 19876599 | Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis. | Invest New Drugs | 2011 | https://conductscience.org/library/papers/19876599 | PubMed |
| 18052411 | Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management. | Paediatr Drugs | 2007 | https://conductscience.org/library/papers/18052411 | PubMed |
| 17990006 | Hypertension in children with chronic kidney disease: pathophysiology and management. | Pediatr Nephrol | 2008 | https://conductscience.org/library/papers/17990006 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17154643
GET https://conductscience.org/api/papers/v1/17154643/references?page=2